Literature DB >> 3039581

Attention deficit disorder with hyperactivity (ADDH): the contribution of catecholaminergic activity.

R D Oades.   

Abstract

An attention deficit disorder with hyperactivity in children (ADDH) is now recognized in most countries although diagnostic practices differ. Evidence is presented to show that the two cardinal symptoms of poor attentional performance and high motor activity may be functionally and causally separate. Both are temporarily relieved in a proportion of subjects that respond to psychostimulants. Beneficial treatment decreases nonadrenergic metabolism and normalizes variable levels of dopaminergic metabolism. Parallels are drawn with other clinical syndromes arising from changed catecholaminergic activity and with behavioral interpretations of the result of damage to the dorsal noradrenergic bundle and dopaminergic A10 nucleus. Prognosis of ADDH subjects after treatment remains poor. There may be a further defect of neurotransmitter metabolism in the ADDH syndrome. Research strategies are suggested based on the neurobiological correlates of the cognitive style of ADDH subjects and septal function in the animal model of the hypertensive rat.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039581     DOI: 10.1016/0301-0082(87)90019-0

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  9 in total

1.  Modest neuropsychological deficits caused by reduced noradrenaline metabolism in mice heterozygous for a mutated tyrosine hydroxylase gene.

Authors:  K Kobayashi; Y Noda; N Matsushita; K Nishii; H Sawada; T Nagatsu; D Nakahara; R Fukabori; Y Yasoshima; T Yamamoto; M Miura; M Kano; T Mamiya; Y Miyamoto; T Nabeshima
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 2.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

3.  Discovery of a potent thiadiazole class of histamine h3 receptor antagonist for the treatment of diabetes.

Authors:  Ashwin U Rao; Ning Shao; Robert G Aslanian; Tin-Yau Chan; Sylvia J Degrado; Li Wang; Brian McKittrick; Mary Senior; Robert E West; Shirley M Williams; Ren-Long Wu; Joyce Hwa; Bhuneshwari Patel; Shuqin Zheng; Christopher Sondey; Anandan Palani
Journal:  ACS Med Chem Lett       Date:  2011-11-21       Impact factor: 4.345

4.  Effects of methylphenidate on attention in Wistar rats treated with the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4).

Authors:  Joachim Hauser; Andreas Reissmann; Thomas-A Sontag; Oliver Tucha; Klaus W Lange
Journal:  J Neural Transm (Vienna)       Date:  2017-01-21       Impact factor: 3.575

5.  D-amphetamine depresses visual responses in the rat superior colliculus: a possible mechanism for amphetamine-induced decreases in distractibility.

Authors:  J D Gowan; V Coizet; I M Devonshire; P G Overton
Journal:  J Neural Transm (Vienna)       Date:  2008-02-26       Impact factor: 3.575

6.  Non-imidazole histamine H3 ligands: part V. synthesis and preliminary pharmacological investigation of 1-[2-thiazol-4-yl- and 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.

Authors:  Roman Guryn; Marek Staszewski; Krzysztof Walczyński
Journal:  Med Chem Res       Date:  2012-11-29       Impact factor: 1.965

7.  Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.

Authors:  Peipei Kang; Limei Luo; Xiling Peng; Yanhu Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

8.  The effects of the neurotoxin DSP4 on spatial learning and memory in Wistar rats.

Authors:  Joachim Hauser; Thomas A Sontag; Oliver Tucha; Klaus W Lange
Journal:  Atten Defic Hyperact Disord       Date:  2012-05-15

9.  Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD.

Authors:  A Bari; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.